Published in
Taylor and Francis Group, Acta Oncologica, 3(50), p. 448-454, 2010
DOI: 10.3109/0284186x.2010.500300
Links
Tools
A Phase I-II dose escalation study of fixed-dose rate gemcitabine, oxaliplatin and capecitabine every two weeks in advanced cholangiocarcinomas
Journal article published in 2010 by
Ulrik Lassen 
,
Lars Henrik Jensen,
Morten Sorensen,
Kristoffer S. Rohrberg,
Zaza Ujmajuridze,
Anders Jakobsen
,
Lars Henrik Jensen,
Morten Sorensen,
Kristoffer S. Rohrberg,
Zaza Ujmajuridze,
Anders Jakobsen
This paper is available in a repository.
Full text: Download
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 